Forus (formerly Tandem), a developer of an AI-powered prior authorizations platform that connects doctors, pharmacies, payers, and biopharma to bring new medicine to patients, raised over $160 million in funding, at a valuation of $1 billion.
The investment round was co-led by Thrive Capital, General Catalyst, Accel, Bain Capital Ventures (BCV), Redpoint, BoxGroup, and Pear VC.
Embedded into physician workflows, the Forus platform automates all steps between a clinical decision and a patient starting treatment, including insurance authorization, financial assistance, and fulfillment routing. Forus supports every drug, payer, and pharmacy in the country and is free for both doctors and patients. By abstracting away complexity, Forus gives doctors the confidence to prescribe the most effective treatments and gives patients the certainty they will receive them.
“Drug discovery is moving faster, but the system that turns it into real-world treatment isn’t,” said Sahir Jaggi, CEO and founder of Forus. “We are creating that missing layer. We’re grateful to the clinicians across the country who already trust Forus to get their patients on treatment. There’s an opportunity to unlock an order of magnitude more treatment options for doctors and patients, and we are building a team whose ambition matches that goal.”
Forus is already used by thousands of medical practices and health systems in all 50 states in the U.S. and is expanding rapidly across specialties.
AI-powered digital health software startups have secured billions of dollars in funding so far in 2026, according to our latest funding database.
More recently, Optura, a provider of an enterprise AI platform that helps healthcare organizations quickly assess the business value of AI and prioritize AI investments in real time, raised $17.5 million in a Series A round. In another deal, XCaliber Health, a developer of an agentic operating system purpose-built to reduce administrative burden and improve the quality of clinical care delivered to patients, raised $6.5 million in Seed funding.